Glen Kristiansen
Glen Kristiansen
Professor für Pathologie
Verified email at
Cited by
Cited by
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
A Schaefer, M Jung, HJ Mollenkopf, I Wagner, C Stephan, F Jentzmik, ...
International journal of cancer 126 (5), 1166-1176, 2010
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W Weichert, A Röske, V Gekeler, T Beckers, C Stephan, K Jung, ...
British journal of cancer 98 (3), 604-610, 2008
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer
C Wissmann, PJ Wild, S Kaiser, S Roepcke, R Stoehr, M Woenckhaus, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
CD24 expression is a new prognostic marker in breast cancer
G Kristiansen, KJ Winzer, E Mayordomo, J Bellach, K Schlüns, ...
Clinical cancer research 9 (13), 4906-4913, 2003
Real‐time elastography—an advanced method of ultrasound: first results in 108 patients with breast lesions
A Thomas, T Fischer, H Frey, R Ohlinger, S Grunwald, JU Blohmer, ...
Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2006
Tumour biological aspects of CD24, a mucin-like adhesion molecule
G Kristiansen, M Sammar, P Altevogt
Journal of molecular histology 35 (3), 255-262, 2004
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
S Runz, S Keller, C Rupp, A Stoeck, Y Issa, D Koensgen, A Mustea, ...
Gynecologic oncology 107 (3), 563-571, 2007
Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
Y Chen, T Knösel, G Kristiansen, A Pietas, ME Garber, S Matsuhashi, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen, C Denkert, K Schlüns, E Dahl, C Pilarsky, S Hauptmann
The American journal of pathology 161 (4), 1215-1221, 2002
Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma
C Denkert, KJ Winzer, BM Müller, W Weichert, S Pest, M Köbel, ...
Cancer 97 (12), 2978-2987, 2003
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
W Weichert, T Knösel, J Bellach, M Dietel, G Kristiansen
Journal of clinical pathology 57 (11), 1160-1164, 2004
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ...
Nature 486 (7402), 266-270, 2012
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
M Jung, HJ Mollenkopf, C Grimm, I Wagner, M Albrecht, T Waller, ...
Journal of cellular and molecular medicine 13 (9b), 3918-3928, 2009
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J Veeck, D Niederacher, H An, E Klopocki, F Wiesmann, B Betz, O Galm, ...
Oncogene 25 (24), 3479-3488, 2006
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non–small cell lung cancer
A Soltermann, V Tischler, S Arbogast, J Braun, N Probst-Hensch, ...
Clinical Cancer Research 14 (22), 7430-7437, 2008
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?
F Ohl, M Jung, C Xu, C Stephan, A Rabien, M Burkhardt, A Nitsche, ...
Journal of molecular medicine 83 (12), 1014-1024, 2005
Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours
F Jentzmik, C Stephan, K Miller, M Schrader, A Erbersdobler, ...
European urology 58 (1), 12-18, 2010
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
P Ström, K Kartasalo, H Olsson, L Solorzano, B Delahunt, DM Berney, ...
The Lancet Oncology 21 (2), 222-232, 2020
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
G Kristiansen, K Schlüns, Y Yongwei, C Denkert, M Dietel, I Petersen
British journal of cancer 88 (2), 231-236, 2003
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis
A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ...
BMC cancer 8 (1), 1-15, 2008
The system can't perform the operation now. Try again later.
Articles 1–20